"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 2 | 2 |
| 1994 | 1 | 3 | 4 |
| 1995 | 3 | 4 | 7 |
| 1996 | 2 | 7 | 9 |
| 1997 | 3 | 6 | 9 |
| 1998 | 0 | 1 | 1 |
| 1999 | 3 | 3 | 6 |
| 2000 | 4 | 6 | 10 |
| 2001 | 2 | 2 | 4 |
| 2002 | 2 | 3 | 5 |
| 2003 | 2 | 7 | 9 |
| 2004 | 2 | 5 | 7 |
| 2005 | 3 | 3 | 6 |
| 2006 | 4 | 4 | 8 |
| 2007 | 7 | 2 | 9 |
| 2008 | 4 | 2 | 6 |
| 2009 | 4 | 7 | 11 |
| 2010 | 6 | 4 | 10 |
| 2011 | 6 | 2 | 8 |
| 2012 | 5 | 1 | 6 |
| 2013 | 4 | 7 | 11 |
| 2014 | 2 | 2 | 4 |
| 2015 | 6 | 5 | 11 |
| 2016 | 1 | 8 | 9 |
| 2017 | 4 | 7 | 11 |
| 2018 | 0 | 4 | 4 |
| 2019 | 5 | 2 | 7 |
| 2020 | 10 | 1 | 11 |
| 2021 | 4 | 0 | 4 |
| 2022 | 4 | 0 | 4 |
| 2023 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy. Blood Adv. 2023 08 22; 7(16):4475-4478.
-
A three-year-old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy. Pediatr Blood Cancer. 2023 Aug; 70(8):e30307.
-
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023 Jul; 58(7):835-838.
-
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
-
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation. Cell Rep. 2023 03 28; 42(3):112250.
-
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies. Blood Adv. 2023 02 28; 7(4):549-554.
-
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia. 2023 04; 37(4):799-806.
-
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022 11 22; 6(22):5898-5907.
-
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Am J Clin Dermatol. 2022 Sep; 23(5):719-728.
-
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplant Cell Ther. 2022 09; 28(9):618.e1-618.e10.